Bryan Coburn

ORCID: 0000-0003-0150-4510
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gut microbiota and health
  • CAR-T cell therapy research
  • Bacterial Identification and Susceptibility Testing
  • Clostridium difficile and Clostridium perfringens research
  • PARP inhibition in cancer therapy
  • Antibiotic Resistance in Bacteria
  • Reproductive tract infections research
  • Cancer Immunotherapy and Biomarkers
  • Antibiotic Use and Resistance
  • Viral gastroenteritis research and epidemiology
  • Salmonella and Campylobacter epidemiology
  • COVID-19 Clinical Research Studies
  • Urinary Tract Infections Management
  • Pancreatic and Hepatic Oncology Research
  • Cystic Fibrosis Research Advances
  • Head and Neck Cancer Studies
  • Escherichia coli research studies
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial biofilms and quorum sensing
  • Vibrio bacteria research studies
  • Sarcoma Diagnosis and Treatment
  • Nosocomial Infections in ICU
  • Transplantation: Methods and Outcomes
  • Mycobacterium research and diagnosis
  • Respiratory viral infections research

University of Toronto
2016-2025

University Health Network
2016-2025

Toronto General Hospital
2017-2025

Toronto General Hospital Research Institute
2018-2025

Health Net
2019-2025

Canada Research Chairs
2015-2024

Sunnybrook Health Science Centre
2024

North York General Hospital
2024

Monash Medical Centre
2024

London Health Sciences Centre
2024

Abstract Understanding the significance of bacterial species that colonize and persist in cystic fibrosis (CF) airways requires a detailed examination community structure across broad range age disease stage. We used 16S ribosomal RNA sequencing to characterize lung microbiota 269 CF patients spanning 60 year range, including 76 pediatric samples from 4–17 cross-section status identify features their relationship stage age. The shows significant inter-individual variability structure,...

10.1038/srep10241 article EN cc-by Scientific Reports 2015-05-14
François-Xavier Lescure Hitoshi Honda Robert Fowler Jennifer Sloane Lazar Genming Shi and 95 more Peter K. Wung Naimish Patel Owen Hagino Ignacio J. Bazzalo Marcelo Martín Casas Sebastián A. Núñez Yael Pere Carlos M. Ibarrola Marco A. Solis Aramayo María Celia Cuesta Andrea E. Duarte Pablo Fernández Maria A. Iannantuono Erica A. Miyazaki Javier P. Silvio Darío Scublinsky Alessandra Martins Bales Daniela Catarino Elie Fiss Sara Mohrbacher Victor Augusto Hamamoto Sato Antonio Baylao Adilson W. Cavalcante Francini Guerra Correa Celso A. de Andrade Juvencio Furtado Nelson Ribeiro Filho Valéria Telles Leopoldo Tosi Trevelin Ricardo Vipich Rodrigo Boldo Paula Borges Suzana M. Lobo Graziela Denardin Luckemeyer Luana Machado Maysa B. Alves Ana Caroline Coutinho Iglessias Marianna M. Lago Daniel Wagner de Castro Lima Santos Hugo Chapdelaine Emilia Liana Falcone Rahima Jamal Me‐Linh Luong Madéleine Durand Stéphane Doucet François Martin Carrier Bryan Coburn Lorenzo Del Sorbo Sharon Walmsley Sara Belga Luke Y. C. Chen Allison Mah Theodore S. Steiner Alissa Wright J Hájek Neill K. J. Adhikari Robert Fowler Nick Daneman Kosar Khwaja Jason Shahin Carolina González Rafael Silva Marcelo Lindh Gabriel Maluenda Patricia Fernández Maite Oyonarte Martín Lasso Alexandre Boyer Didier Brönnimann Hoang-Nam Bui Charles Cazanave H. Chaussade Arnaud Desclaux M. Ducours Alexandre Duvignaud Denis Malvy Lisa J. Martin D. Neau Duc Thanh Nguyen Thierry Pistone Gaetane Soubrane-Wirth Julie Leitao Clotilde Allavena Charlotte Biron Sabelline Bouchez Benjamin Gaborit Antoine Grégoire Paul Le Turnier Anne-Sophie Lecompte R. Lecomte M. Lefèbvre F. Raffi D. Boutoille P Morineau Romain Guéry

Elevated proinflammatory cytokines are associated with greater COVID-19 severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, in patients severe (requiring supplemental oxygen by nasal cannula or face mask) critical oxygen, mechanical ventilation, extracorporeal support) COVID-19.We did a 60-day, randomised, double-blind, placebo-controlled, multinational phase 3 trial at 45 hospitals Argentina, Brazil, Canada, Chile, France, Germany, Israel,...

10.1016/s2213-2600(21)00099-0 article EN other-oa The Lancet Respiratory Medicine 2021-03-07

To date, only monoclonal antibodies have been shown to be effective for outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate antiviral responses activity against respiratory pathogens. We aimed investigate the safety and efficacy of peginterferon lambda treatment mild-to-moderate COVID-19.In this double-blind, placebo-controlled trial, laboratory-confirmed COVID-19 were randomly assigned single subcutaneous injection 180 μg or placebo within 7 days...

10.1016/s2213-2600(20)30566-x article EN other-oa The Lancet Respiratory Medicine 2021-02-07

Fecal transplantation (FT) is a promising treatment for recurrent Clostridium difficile infection (CDI), but its true effectiveness remains unknown. We compared 14 days of oral vancomycin followed by single FT enema with taper (standard care) in adult patients experiencing acute recurrence CDI.In phase 2/3, single-center, open-label trial, participants from Ontario, Canada, CDI were randomly assigned 1:1 ratio to 500-mL enema, or 6-week vancomycin. Patients significant immunocompromise,...

10.1093/cid/ciw731 article EN Clinical Infectious Diseases 2016-11-01

Abstract The intestinal immune system is emerging as an important contributor to obesity-related insulin resistance, but the role of B cells in this context unclear. Here, we show that high fat diet (HFD) feeding alters IgA + and a critical regulator glucose homeostasis. Obese mice have fewer less secretory IgA-promoting mediators. HFD-fed IgA-deficient dysfunctional metabolism, phenotype can be recapitulated by adoptive transfer intestinal-associated pan-B cells. Mechanistically, crucial...

10.1038/s41467-019-11370-y article EN cc-by Nature Communications 2019-08-13

Salmonella species cause a wide range of disease in multiple hosts. enterica serovar Typhimurium causes self-limited intestinal humans and systemic typhoid-like illness susceptible mice. The prevailing dogma murine S. pathogenesis is that distinct virulence mechanisms-Salmonella pathogenicity islands 1 2 (SPI1 SPI2)-perform roles pathogenesis, the former being important for invasion latter intracellular survival persistence disease. Although evidence from bovine infections has suggested SPI2...

10.1128/iai.73.6.3219-3227.2005 article EN Infection and Immunity 2005-05-20

ABSTRACT Pulmonary infections caused by Pseudomonas aeruginosa are a recalcitrant problem in cystic fibrosis (CF) patients. While the clinical implications and long-term evolutionary patterns of these well studied, we know little about short-term population dynamics that enable this pathogen to persist despite aggressive antimicrobial therapy. Here, describe genomic analysis 233 P. isolates collected from 12 sputum specimens obtained over 1-year period single patient. Whole-genome sequencing...

10.1128/mbio.00981-15 article EN cc-by-nc-sa mBio 2015-09-02

Abstract Chronic airway infections caused by Pseudomonas aeruginosa contribute to the progression of pulmonary disease in individuals with cystic fibrosis (CF). In setting CF, within-patient adaptation a P. strain generates phenotypic diversity that can complicate microbiological analysis patient samples. We investigated within- and between- sample 34 phenotypes among 235 isolates cultured from sputum samples collected single CF over span one year assessed colony morphology as screening tool...

10.1038/srep10932 article EN cc-by Scientific Reports 2015-06-05

Background. Bacterial vaginosis (BV) causes genital inflammation and increases HIV risk, whereas a vaginal microbiota dominated by Lactobacillus species is associated with immune quiescence relative protection. BV treatment reduces inflammation, but it unclear whether this reduction driven decrease in BV-associated bacteria or an increase species.

10.1172/jci152930 article EN cc-by Journal of Clinical Investigation 2022-02-03

The intestinal microbiome has been associated with response to immune checkpoint inhibitors (ICIs) in humans and causally implicated ICI responsiveness animal models. Two recent human trials demonstrated that fecal microbiota transplant (FMT) from responders can rescue responses refractory melanoma, but FMT specific limitations scaled use.We conducted an early-phase clinical trial of a cultivated, orally delivered 30-species microbial consortium (Microbial Ecosystem Therapeutic 4, MET4)...

10.1016/j.annonc.2023.02.011 article EN cc-by-nc-nd Annals of Oncology 2023-03-01

Abstract Two common features of dietary polyphenols have hampered our mechanistic understanding their beneficial effects for decades: targeting multiple organs and extremely low bioavailability. We show here that resveratrol intervention (REV-I) in high-fat diet (HFD)-challenged male mice inhibits chylomicron secretion, associated with reduced expression jejunal but not hepatic scavenger receptor class B type 1 (SR-B1). Intestinal mucosa-specific SR-B1 -/- on HFD-challenge exhibit improved...

10.1038/s41467-023-38259-1 article EN cc-by Nature Communications 2023-05-09

Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment uncertain.

10.1056/nejmoa2404991 article EN New England Journal of Medicine 2024-11-20

Genital inflammation increases HIV susceptibility and is associated with the density of pro-inflammatory anaerobes in vagina coronal sulcus. The penile urethra a critical site acquisition, although correlates urethral acquisition are largely unknown. While Streptococcus mitis consistent component flora, presence Gardnerella vaginalis has been linked prior penile-vaginal sex inflammation. Here, we use flow cytometry-based bacterial assay to quantify IgA IgG that bind G. S. cross-sectional...

10.1186/s40168-024-02007-4 article EN cc-by Microbiome 2025-01-29

We have developed a novel ileal loop model for use in calves to analyze the contribution of Salmonella enterica serovar Typhimurium type III secretion systems disease processes vivo. Our involves constructing loops with end-to-end anastamoses restore patency small intestine, thereby allowing experimental animals convalesce following surgery desired number days. This overcomes time constraint imposed by ligated models that precluded investigation virulence factors during later stages...

10.1128/iai.73.11.7161-7169.2005 article EN Infection and Immunity 2005-10-26

Salmonella enterica serovar Typhimurium is a facultative intracellular pathogen that causes disease in mice resembles human typhoid. Typhoid pathogenesis consists of distinct phases the intestine and subsequent systemic phase which bacteria replicate macrophages liver spleen. The type III secretion system encoded by pathogenicity island 2 (SPI-2) major virulence factor contributing to typhoid pathogenesis. Understanding how pathogens regulate mechanisms response environment, including...

10.1371/journal.ppat.0010032 article EN cc-by PLoS Pathogens 2005-11-16

Although O157:H7 Shiga toxin-producing Escherichia coli (STEC) are the predominant cause of hemolytic-uremic syndrome (HUS) in world, non-O157:H7 serotypes a medically important HUS that underdetected by current diagnostic approaches. Because toxin is necessary but not sufficient to HUS, identifying virulence determinants predict severe disease after non-O157 STEC infection paramount importance. Disease caused has been associated with 26-gene pathogenicity island known as O (OI) 122. To...

10.1086/506620 article EN The Journal of Infectious Diseases 2006-08-22

Abstract Over 90% of cystic fibrosis (CF) patients die due to chronic lung infections leading respiratory failure. The decline in CF function is greatly accelerated by intermittent and progressively severe acute pulmonary exacerbations (PEs). Despite their clinical impact, surprisingly few microbiological signals associated with PEs have been identified. Here we introduce an unsupervised, systems-oriented approach identify key members the microbiota. We used two sputum microbiome data sets...

10.1038/s41522-018-0077-y article EN cc-by npj Biofilms and Microbiomes 2019-01-11
Coming Soon ...